Search company, investor...

Founded Year



Corporate Majority | Alive

About Sinovant Sciences

Sinovant Sciences is a Shanghai-based biopharmaceutical company dedicated to bringing innovative medicines to China and advancing Chinese biopharmaceutical innovation abroad. Sinovant has built a pipeline of 11 investigational biopharmaceutical products for Greater China and other Asian markets, including four therapies suitable for Phase 3 clinical trial application or registration in China. Sinovant's investigational therapies address several of China's greatest public health priorities, including liver cancer and drug-resistant bacterial infections.

Headquarters Location

Shanghai, Shanghai,




Latest Sinovant Sciences News

Sinovant Says Antibiotic Effective for Pneumonia; Transfers China Rights to Sumitomo

May 27, 2021

publication date: May 27, 2021 Sinovant Sciences, a China adults with community acquired bacterial pneumonia (CABP). The trial showed lefamulin was non-inferior to IV/oral moxifloxacin in patients with CABP. In 2017, Sinovant acquired China Vienna China Suzhou Share this with colleagues: Sorry this page is available to subscribers only. If you're not a subscriber why not subscribe today? If you are already a subscriber, please login. If you believe you should have received this message in error, please contact us .

Sinovant Sciences Frequently Asked Questions (FAQ)

  • When was Sinovant Sciences founded?

    Sinovant Sciences was founded in 2017.

  • Where is Sinovant Sciences's headquarters?

    Sinovant Sciences's headquarters is located at Shanghai.

  • What is Sinovant Sciences's latest funding round?

    Sinovant Sciences's latest funding round is Corporate Majority.

  • Who are the investors of Sinovant Sciences?

    Investors of Sinovant Sciences include Roivant Sciences and CPE.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.